TNG462, S095035 tablet 25mg, S095035 tablet 50mg, TNG462, TNG462
CL1-95035-001
Phase 2 small_molecule active
Quick answer
TNG462, S095035 tablet 25mg, S095035 tablet 50mg, TNG462, TNG462 for MTAP-deleted advanced or metastatic solid tumors is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- MTAP-deleted advanced or metastatic solid tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active